| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/24/2004 | US6696411 Genetic expression vectors comprising polynucleotides which codes for glycoprotein hormones, administered as progentor cell stimulants or as therapy for blood disorders; veterinary medicine |
| 02/24/2004 | US6696410 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 02/24/2004 | US6696409 Ligands for neurotransmitter receptors, administered as decongestants and hypotensive agents, or for prophylaxis of cardiovascular and urogenital disorders |
| 02/24/2004 | US6696408 Administering glycosylated polypeptides as antiepileptics and anticonvulsants or for prophylaxis of psychological disorders |
| 02/24/2004 | US6696396 Therapeutic soap |
| 02/24/2004 | US6696303 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 02/24/2004 | US6696290 Genetic engineered multimeric proteins having extracellular domains of oncogenes which code transmembrane receptors, used as competitive antagonists or agonists of neuregulins; anticarcinogenic agents |
| 02/24/2004 | US6696280 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections |
| 02/24/2004 | US6696279 Modulating methionine adenosyltransferase ii (mat ii) catalytic activity |
| 02/24/2004 | US6696274 Polypeptides capable of crossing the small intestine or blood brain barrier; bioavailability |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696247 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/24/2004 | US6696242 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 02/24/2004 | US6696090 Micronized medical powder electrostatically charged by corona, induction, or triboelectricity; lung airway or oral inhalation administration of antiasthmatic agent |
| 02/24/2004 | US6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 02/24/2004 | US6696088 Useful for decreasing the potential for abuse of the opioid agonist contained therein; for use in therapy of pain |
| 02/24/2004 | US6696083 Administering vitamin b1, thiamine, niacinamide, folic acid, riboflavin, pantothenic acid, vitamin b, pyridoxine, and/or vitamin b12 to human during sleep; oxidation resistance |
| 02/24/2004 | US6696063 Administering human growth hormone derivative |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696061 Binds human major histocompatibility complex (mhc) class ii allotype |
| 02/24/2004 | US6696059 Administering to patient a therapeutically effective amount of both an n-alkyl derivative of deoxynojirimycin and a glucocerebrosidase enzyme to alleviate or inhibit glycolipid storage disease; gaucher's disease |
| 02/24/2004 | US6696056 Pharmaceutical compositions of erythropoietin |
| 02/24/2004 | US6696038 Cationic lipopolymer as biocompatible gene delivery agent |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/23/2004 | CA2399548A1 Growth hormone-releasing peptides as negative modulators of atherosclerosis and hypercholesterolemia |
| 02/19/2004 | WO2004016297A1 Composition for filling bone defects |
| 02/19/2004 | WO2004015425A1 Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha |
| 02/19/2004 | WO2004015392A2 Improved method to identify targeting molecules |
| 02/19/2004 | WO2004015143A2 Endosymbiotic gammaproteobacterium identified in ecteinascidia turbinata |
| 02/19/2004 | WO2004015135A1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 02/19/2004 | WO2004015131A2 Hepatitis c virus assays |
| 02/19/2004 | WO2004015126A2 Antisense modulation of edg1 expression |
| 02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
| 02/19/2004 | WO2004015113A2 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
| 02/19/2004 | WO2004015106A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | WO2004015096A2 Leech extracts for stents |
| 02/19/2004 | WO2004015086A2 Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product |
| 02/19/2004 | WO2004015079A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | WO2004015078A2 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 02/19/2004 | WO2004015075A2 Short interfering rnas having a hairpin structure containing a non-nucleotide loop |
| 02/19/2004 | WO2004015067A2 Sperm-specific cation channel, catsper-3, and uses therefor |
| 02/19/2004 | WO2004015058A2 Nephritis treatment by gene therapy |
| 02/19/2004 | WO2004015057A2 Mucin-immunoglobulin fusion proteins |
| 02/19/2004 | WO2004014955A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 02/19/2004 | WO2004014950A1 INTERFERON-α INDUCED GENE |
| 02/19/2004 | WO2004014947A1 Method for isolating an intestinal cholesterol binding protein |
| 02/19/2004 | WO2004014946A1 A novel homo protein with cancer suppressing function and its coding sequence |
| 02/19/2004 | WO2004014945A1 Gp41 epitope and uses thereof for the treatment of hiv infections |
| 02/19/2004 | WO2004014943A2 Biphalin derivates and their analgesic applications |
| 02/19/2004 | WO2004014940A2 PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS |
| 02/19/2004 | WO2004014938A2 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 02/19/2004 | WO2004014937A2 Thrombin peptide derivatives |
| 02/19/2004 | WO2004014882A2 Proteasome inhibitors : peptide derivatives having c-terminal heteroaryl groups |
| 02/19/2004 | WO2004014852A2 Iminothiazolidinones as inhibitors of hcv replication |
| 02/19/2004 | WO2004014424A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 02/19/2004 | WO2004014420A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | WO2004014415A1 Growth hormone releasing peptides |
| 02/19/2004 | WO2004014414A1 Novel uses of rfrp and ot7t022 |
| 02/19/2004 | WO2004014413A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 02/19/2004 | WO2004014412A1 Myocardial cell protecting agents |
| 02/19/2004 | WO2004014396A1 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
| 02/19/2004 | WO2004014367A2 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 02/19/2004 | WO2004014359A1 Regulation of apob in treatment and drug screening for cardiovascular and metabolic disorders or syndromes |
| 02/19/2004 | WO2004014351A2 Use of cgrp antagonist compounds for treatment of psoriasis |
| 02/19/2004 | WO2004014349A1 New molecules for modulating drug resistance in fungus |
| 02/19/2004 | WO2004014314A2 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | WO2004014313A2 Combination pharmaceutical agents as inhibitors of hcv replication |
| 02/19/2004 | WO2004014303A2 Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density |
| 02/19/2004 | WO2004014302A2 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | WO2004005326A3 Tubulysin conjugates |
| 02/19/2004 | WO2004003154A3 Use of streptavidin to inhibit transplant rejection |
| 02/19/2004 | WO2004003133A8 Pain signaling molecules |
| 02/19/2004 | WO2003102584A3 Semaphorin-like proteins and methods of using same |
| 02/19/2004 | WO2003102129A3 Photorhabdus luminescens mcf toxin genes and uses thereof |
| 02/19/2004 | WO2003099857B1 Antagonistic peptides of prostaglandin e2 receptor subtype ep4 |
| 02/19/2004 | WO2003097852A3 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/19/2004 | WO2003097834A3 A method for in vitro molecular evolution of protein function |
| 02/19/2004 | WO2003095647A3 CHIMERIC snRNA MOLECULES CARRYING ANTISENSE SEQUENCES AGAINST THE SPLICE JUNCTIONS OF THE DYSTROPHIN GENE AND THEIR THERAPEUTIC APPLICATIONS |
| 02/19/2004 | WO2003092603A3 Composition and method for reducing post-prandial blood glucose |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003087318A3 Truncated 24 kda basic fibroblast growth factor |
| 02/19/2004 | WO2003085124A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003079968A3 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ |
| 02/19/2004 | WO2003078574A3 Novel metabolic targets and markers |
| 02/19/2004 | WO2003070904A3 Human rnase iii and compositions and uses thereof |
| 02/19/2004 | WO2003070188A3 Method of treating trx mediated diseases |
| 02/19/2004 | WO2003065987A3 Granzyme b inhibitors |
| 02/19/2004 | WO2003065046A3 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 02/19/2004 | WO2003065045A3 Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
| 02/19/2004 | WO2003065010A3 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis |
| 02/19/2004 | WO2003064602A3 Methods of modulating cold sensory perception |
| 02/19/2004 | WO2003064460A3 Two gonadotropin releasing hormones and a method to isolate the same |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | WO2003048780A3 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 02/19/2004 | WO2003048297A3 Regulation of human atp-binding cassette transporter 1 like-protein |